Literature DB >> 8790030

Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial.

.   

Abstract

BACKGROUND: A mortality follow-up of 12,866 men was conducted 16 years after randomization to special intervention (SI) or usual care (UC) groups of the Multiple Risk Factor Intervention Trial to assess the long-term effect of cardiovascular risk factor intervention on coronary heart disease (CHD), cardiovascular death (CVD), and total mortality. METHODS AND
RESULTS: During the 7-year active-intervention phase of the trial, 6428 of the men were given dietary recommendations to lower blood cholesterol, antihypertensive drugs to lower blood pressure, and counseling for cigarette smoking cessation. The remaining 6438 men were referred to their usual source of medical care. After 16 years, 370 SI and 417 UC men had died from CHD, which represents an 11.4% lower mortality rate for SI versus UC men (95% CI, -23% to 1.9%). Results for total mortality followed a similar pattern; 991 SI and 1050 UC men had died by the end of follow-up (relative difference, -5.7%; 95% CI, -13% to 2.8%). For acute myocardial infarction, a subcategory of CHD, the relative difference was -20.4% (95% CI, -34.4% to -3.4%). Differences between SI and UC men in mortality rates from acute myocardial infarction, CHD, and all causes were greater during the posttrial follow-up period than during the trial.
CONCLUSIONS: Results of a 7-year multifactor intervention program aimed at lowering blood pressure and serum cholesterol and at cigarette smoking cessation among high-risk men give additional evidence of a long-term, continuing mortality benefit from the program.

Entities:  

Mesh:

Year:  1996        PMID: 8790030     DOI: 10.1161/01.cir.94.5.946

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

1.  Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women.

Authors:  Thomas Rutledge; Sarah E Linke; B Delia Johnson; Vera Bittner; David S Krantz; Carol E Cornell; Viola Vaccarino; Carl J Pepine; Eileen M Handberg; Wafia Eteiba; Leslee J Shaw; Susmita Parashar; Jo-Ann Eastwood; Diane A Vido; C Noel Bairey Merz
Journal:  J Womens Health (Larchmt)       Date:  2011-10-11       Impact factor: 2.681

2.  The limitations of opportunistic epidemiology, pseudopod epidemiology.

Authors:  Lewis H Kuller
Journal:  Eur J Epidemiol       Date:  2016-09-03       Impact factor: 8.082

3.  The diagnostic yield of exercise stress testing as a screening tool for subclinical coronary artery disease in patients with moderate to severe obstructive sleep apnea.

Authors:  Aykut Cilli; Fulsen Batmaz; Ibrahim Demir; Adil Boz; Evren Toprak; Tülay Ozdemir; Yüksel Peker
Journal:  J Clin Sleep Med       Date:  2011-02-15       Impact factor: 4.062

4.  Increased Mortality Despite Successful Multifactorial Cardiovascular Risk Reduction in Healthy Men: 40-Year Follow-Up of the Helsinki Businessmen Study Intervention Trial.

Authors:  T E Strandberg; K Räikkönen; V Salomaa; A Strandberg; H Kautiainen; M Kivimäki; K Pitkälä; J Huttunen
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

5.  Community based lifestyle intervention for blood pressure reduction in children and young adults in developing country: cluster randomised controlled trial.

Authors:  Tazeen H Jafar; Muhammad Islam; Juanita Hatcher; Shiraz Hashmi; Rasool Bux; Ayesha Khan; Neil Poulter; Salma Badruddin; Nish Chaturvedi
Journal:  BMJ       Date:  2010-06-07

Review 6.  Improved patient outcome with smoking cessation: when is it too late?

Authors:  Jane Wu; Don D Sin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-05-02

7.  Screening for coronary artery disease in patients with type 2 diabetes mellitus: An evidence-based review.

Authors:  Sandeep Chopra; Soumia Peter
Journal:  Indian J Endocrinol Metab       Date:  2012-01

8.  Is Peri-Operative Isolated Systolic Hypertension (ISH) a Cardiac Risk Factor?

Authors:  Ashraf Fayad; Homer Yang
Journal:  Curr Cardiol Rev       Date:  2008-02

9.  Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial.

Authors:  Jeremiah Stamler; James D Neaton; Jerome D Cohen; Jeffrey Cutler; Lynn Eberly; Gregory Grandits; Lewis H Kuller; Judith Ockene; Ronald Prineas
Journal:  J Am Heart Assoc       Date:  2012-10-25       Impact factor: 5.501

10.  Control of Blood Pressure and Risk Attenuation: Post Trial Follow-Up of Randomized Groups.

Authors:  Tazeen H Jafar; Imtiaz Jehan; Feng Liang; Sylvaine Barbier; Muhammad Islam; Rasool Bux; Aamir Hameed Khan; Nivedita Nadkarni; Neil Poulter; Nish Chaturvedi; Shah Ebrahim
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.